Donald J. Jones, a Digital Therapeutics Expert Joins the BODs of Theranica

This Week’s News in Review

This Week's News in Review! Medical Device News Magazine keeps our readers up-to-date on breaking industry news! Learn how Medical Device News Magazine can help...

New Research Shows Nearly Half of Elderly Suffer Decreased Mobility During Lockdown

In a survey of UK adults with parents over the age of 75, while over half (52%) of respondents remain worried about their parents catching Covid, 48 percent are concerned about parental loneliness, and 46 percent about their parents falling alone and not being able to get up or get help. This figure remained high even among those whose parents are in care homes, with 37% of respondents still most concerned about parents falling over.

American College of Cardiology Names Ravee Kurian COO/CFO

Kurian comes to ACC following a 20-year stint at Publicis Sapient, a leading technology and communications consultancy, where he led critical and sensitive digital transformation initiatives for Fortune 500 and U.S. federal clients.

January 19, 2021

Donald J. Jones is a digital therapeutics expert who has joined the board of directors of Theranica.

Donald J. Jones said, “I am honored by the opportunity to join Theranica’s board and am excited to contribute to the success of Nerivio.”  “Theranica is uniquely positioned to advance the non-pharmacological pain therapy industry. Nerivio is an innovative treatment for migraine, a condition that plagues too many people. I look forward to working closely with the talented management team and other board members to drive the company forward and further expand the US customer base.”

Donald J. Jones has spent more than 35 years developing, founding, growing, and scaling national and international healthcare enterprises, such as MedTrans, EMME, HealthCap, and others. For over a decade Mr. Jones served as Qualcomm’s Vice President and founded Qualcomm’s digital health subsidiary. He serves as Chief Digital Officer at Scripps Research Translational Institute, and as an independent board member for venture capital and private equity-backed health companies and on Fortune 1000 Digital Health Advisory Boards, and is globally recognized for his digital transformation expertise.

“Mr. Jones brings complementary knowhow and experience in growing and scaling digital therapeutics companies, and we’re thrilled to collaborate with him to make a national and global impact in the health-tech market,” said Theranica Co-founder and CEO, Alon Ironi. “He joins us at an exciting time, as demand for Nerivio continues to grow and we serve more and more people suffering from migraine. We welcome him and are thrilled to work together with him.”

Theranica’s FDA-cleared prescribed migraine therapeutic wearable Nerivio®, is worn on the upper arm and utilizes Remote Electrical Neuromodulation, controlled from a smartphone, to activate the brain’s native Conditioned Pain Modulation mechanism to treat pain and associated migraine symptoms.

spot_img

DON'T MISS

Dr Jonathan Slotkin Appointed to Peer Well Board of Directors

Alongside the appointment, PeerWell is launching its new clinical practice, PeerWell Health.

Zimmer Biomet Announces New Appointments to Executive Leadership Team

Wilfred van Zuilen Appointed as President of Europe, Middle East and Africa. Nitin Goyal, M.D. Appointed to Newly Created Role of Chief Science, Technology and Innovation Officer.

Subscribe to Medical Device News Magazine here.

Related Articles

Join our list

Subscribe to our mailing list and receive an end-of-week recap news and updates delivered right to your email inbox.